Salvatore DiBartolo

632 total citations
6 papers, 397 citations indexed

About

Salvatore DiBartolo is a scholar working on Molecular Biology, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Salvatore DiBartolo has authored 6 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Nephrology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Salvatore DiBartolo's work include Renal Diseases and Glomerulopathies (2 papers), Extracellular vesicles in disease (1 paper) and Cardiac Fibrosis and Remodeling (1 paper). Salvatore DiBartolo is often cited by papers focused on Renal Diseases and Glomerulopathies (2 papers), Extracellular vesicles in disease (1 paper) and Cardiac Fibrosis and Remodeling (1 paper). Salvatore DiBartolo collaborates with scholars based in United States, Australia and Saudi Arabia. Salvatore DiBartolo's co-authors include Martin R. Pollak, David J. Friedman, Johannes Schlöndorff, Jung Hee Suh, John F. Heneghan, Seth L. Alper, Nathan H. Zahler, Lynn VerPlank, Paul Yan and Opeyemi A. Olabisi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Society of Nephrology and American Journal Of Pathology.

In The Last Decade

Salvatore DiBartolo

6 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Salvatore DiBartolo United States 6 274 130 106 52 37 6 397
Lucie Bessenay France 8 221 0.8× 167 1.3× 45 0.4× 34 0.7× 102 2.8× 9 426
Emiko Fujita Japan 13 204 0.7× 95 0.7× 36 0.3× 69 1.3× 65 1.8× 18 418
Piyanuch Radinahamed Thailand 11 297 1.1× 189 1.5× 11 0.1× 107 2.1× 30 0.8× 17 469
Fangrui Ding China 10 177 0.6× 121 0.9× 24 0.2× 33 0.6× 19 0.5× 23 310
Yoshiaki Hirayama Japan 11 240 0.9× 159 1.2× 12 0.1× 59 1.1× 39 1.1× 23 455
M Mozes Hungary 6 209 0.8× 239 1.8× 26 0.2× 55 1.1× 70 1.9× 8 478
Grazia Soccio Italy 11 90 0.3× 110 0.8× 23 0.2× 62 1.2× 83 2.2× 19 361
David Walsh United States 7 70 0.3× 258 2.0× 23 0.2× 30 0.6× 121 3.3× 25 500
Gustavo Pérez de Nanclares Spain 14 83 0.3× 257 2.0× 15 0.1× 31 0.6× 75 2.0× 36 496

Countries citing papers authored by Salvatore DiBartolo

Since Specialization
Citations

This map shows the geographic impact of Salvatore DiBartolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salvatore DiBartolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salvatore DiBartolo more than expected).

Fields of papers citing papers by Salvatore DiBartolo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salvatore DiBartolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salvatore DiBartolo. The network helps show where Salvatore DiBartolo may publish in the future.

Co-authorship network of co-authors of Salvatore DiBartolo

This figure shows the co-authorship network connecting the top 25 collaborators of Salvatore DiBartolo. A scholar is included among the top collaborators of Salvatore DiBartolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salvatore DiBartolo. Salvatore DiBartolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Altintas, Mehmet M., et al.. (2021). Metabolic Changes in Peripheral Blood Mononuclear Cells Isolated From Patients With End Stage Renal Disease. Frontiers in Endocrinology. 12. 629239–629239. 17 indexed citations
2.
Shah, Trushil, Shanshan Qin, Dan Predescu, et al.. (2018). Alk5/Runx1 signaling mediated by extracellular vesicles promotes vascular repair in acute respiratory distress syndrome. Clinical and Translational Medicine. 7(1). 19–19. 25 indexed citations
3.
Patel, Monal, Dan Predescu, Jiwang Chen, et al.. (2017). Modulation of Intersectin-1s Lung Expression Induces Obliterative Remodeling and Severe Plexiform Arteriopathy in the Murine Pulmonary Vascular Bed. American Journal Of Pathology. 187(3). 528–542. 13 indexed citations
4.
Olabisi, Opeyemi A., Lynn VerPlank, Nathan H. Zahler, et al.. (2015). APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases. Proceedings of the National Academy of Sciences. 113(4). 830–837. 153 indexed citations
5.
Toka, Hakan R., Khaldoun Al‐Romaih, Salvatore DiBartolo, et al.. (2012). Deficiency of the Calcium-Sensing Receptor in the Kidney Causes Parathyroid Hormone–Independent Hypocalciuria. Journal of the American Society of Nephrology. 23(11). 1879–1890. 106 indexed citations
6.
Powe, Camille E., Julia Wenger, Chunmei Huang, et al.. (2011). Genetic Variation in APOL1 Associates with Younger Age at Hemodialysis Initiation. Journal of the American Society of Nephrology. 22(11). 2091–2097. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026